Compliance In Focus

Oftentimes there are questions about doing research with medical devices (as opposed to pharmaceuticals).  We recently highlighted in our whitepaper on the differences (and similarities) of doing research with drugs vs. devices, and also have an infographic summarizing the main points.

Several years ago, IMARC Research published a whitepaper outlining the similarities and differences between drug and device clinical trials.  Since IMARC focuses primarily in the medical device space, we felt it was important to highlight the differences between the two trials.  It has proven to be one of our more popular whitepapers, so we have decided to offer an infographic as a quick reference.

IMARC Research’s whitepaper investigates the differences between the drug and medical device clinical research process.  First and foremost, there is a common thread that ties the seemingly different clinical research processes together…patients.  Real people exist on the other side of an investigational product and they face risk when they choose to take part in a clinical research study.  So while the investigations of drugs and devices have their differences, by design these differences are intended to accomplish the game goal:  to safeguard those research participants while bringing safe and effective products to the market as quickly as possible.

IMARC Research’s whitepaper investigates the differences between the drug and medical device clinical research process.  First and foremost, there is a common thread that ties the seemingly different clinical research processes together…patients.  Real people exist on the other side of an investigational product and they face risk when they choose to take part in a clinical research study.  So while the investigations of drugs and devices have their differences, by design these differences are intended to accomplish the game goal:  to safeguard those research participants while bringing safe and effective products to the market as quickly as possible.